.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Colorcon
Baxter
Mallinckrodt
Cipla
Teva
Deloitte
Accenture
Daiichi Sankyo
Farmers Insurance

Generated: June 22, 2017

DrugPatentWatch Database Preview

NANDROLONE DECANOATE Drug Profile

« Back to Dashboard

What is the patent landscape for Nandrolone Decanoate, and what generic Nandrolone Decanoate alternatives are available?

Nandrolone Decanoate is a drug marketed by Abraxis Pharm, Akorn, Watson Labs, and Pharmaforce. and is included in ten NDAs.

The generic ingredient in NANDROLONE DECANOATE is nandrolone decanoate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nandrolone decanoate profile page.

Summary for Tradename: NANDROLONE DECANOATE

Patents:0
Applicants:4
NDAs:10
Suppliers / Packagers: see list1
Bulk Api Vendors: see list29
Clinical Trials: see list15
Patent Applications: see list613
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NANDROLONE DECANOATE at DailyMed

Pharmacology for Tradename: NANDROLONE DECANOATE

Drug ClassAndrogen
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm
NANDROLONE DECANOATE
nandrolone decanoate
INJECTABLE;INJECTION088317-001Oct 14, 1983DISCNNoNo► Subscribe► Subscribe
Abraxis Pharm
NANDROLONE DECANOATE
nandrolone decanoate
INJECTABLE;INJECTION088290-001Oct 3, 1983DISCNNoNo► Subscribe► Subscribe
Pharmaforce
NANDROLONE DECANOATE
nandrolone decanoate
INJECTABLE;INJECTION091252-001Aug 30, 2010RXNoYes► Subscribe► Subscribe
Watson Labs
NANDROLONE DECANOATE
nandrolone decanoate
INJECTABLE;INJECTION087598-001Oct 6, 1983DISCNNoNo► Subscribe► Subscribe
Akorn
NANDROLONE DECANOATE
nandrolone decanoate
INJECTABLE;INJECTION087519-001Sep 28, 1983DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Express Scripts
Deloitte
Baxter
Merck
Boehringer Ingelheim
Julphar
Accenture
Chubb
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot